Omnicell Future Growth
Future criteria checks 3/6
Omnicell is forecast to grow earnings and revenue by 116.1% and 4.6% per annum respectively. EPS is expected to grow by 116.8% per annum. Return on equity is forecast to be 7% in 3 years.
Key information
116.1%
Earnings growth rate
116.8%
EPS growth rate
| Medical Equipment earnings growth | 17.8% |
| Revenue growth rate | 4.6% |
| Future return on equity | 7.0% |
| Analyst coverage | Good |
| Last updated | 23 Aug 2024 |
Recent future growth updates
Recent updates
Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%
Aug 02
Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?
Jul 11Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Jun 16Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt
May 25An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued
Mar 28Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 29Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Feb 23Omnicell Is Building A Strong Moat
Feb 22Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?
Jan 15Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Dec 25Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?
Dec 06Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%
Nov 10Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?
Sep 06Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?
Aug 08Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching
Jul 02A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Jun 08Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital
Apr 29Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Apr 11At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?
Mar 23Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?
Feb 28Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)
Jan 15We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt
Jan 01Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?
Nov 17Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers
Nov 03Omnicell launches Specialty Pharmacy Services
Oct 11Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly
Sep 30Omnicell says advance services to drive profitable growth in long-run: Investor Day
Sep 20Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Sep 15Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger
Aug 31Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook
Aug 04Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?
Aug 03Omnicell Fails To Justify Inclusion In Long-Only, Equity-Focused Portfolio
Jul 21We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease
Jun 27Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Jun 13Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher
May 30These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely
May 05Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,202 | 30 | 61 | 122 | 4 |
| 12/31/2025 | 1,144 | 19 | 35 | 111 | 8 |
| 12/31/2024 | 1,091 | 2 | 29 | 117 | 8 |
| 6/30/2024 | 1,080 | -21 | 152 | 204 | N/A |
| 3/31/2024 | 1,103 | -21 | 165 | 218 | N/A |
| 12/31/2023 | 1,147 | -20 | 126 | 181 | N/A |
| 9/30/2023 | 1,186 | -34 | 165 | 225 | N/A |
| 6/30/2023 | 1,235 | -23 | 127 | 189 | N/A |
| 3/31/2023 | 1,268 | -18 | 48 | 107 | N/A |
| 12/31/2022 | 1,296 | 6 | 17 | 78 | N/A |
| 9/30/2022 | 1,309 | 48 | -5 | 55 | N/A |
| 6/30/2022 | 1,258 | 61 | 18 | 77 | N/A |
| 3/31/2022 | 1,199 | 72 | 98 | 158 | N/A |
| 12/31/2021 | 1,132 | 78 | 173 | 232 | N/A |
| 9/30/2021 | 1,070 | 80 | 195 | 249 | N/A |
| 6/30/2021 | 987 | 60 | 194 | 242 | N/A |
| 3/31/2021 | 914 | 35 | 164 | 218 | N/A |
| 12/31/2020 | 892 | 32 | 131 | 186 | N/A |
| 9/30/2020 | 891 | 38 | 86 | 144 | N/A |
| 6/30/2020 | 906 | 49 | 101 | 164 | N/A |
| 3/31/2020 | 924 | 69 | 85 | 144 | N/A |
| 12/31/2019 | 897 | 61 | 83 | 145 | N/A |
| 9/30/2019 | 860 | 54 | 98 | 158 | N/A |
| 6/30/2019 | 836 | 48 | 59 | 117 | N/A |
| 3/31/2019 | 807 | 38 | 55 | 112 | N/A |
| 12/31/2018 | 787 | 38 | 50 | 104 | N/A |
| 9/30/2018 | 772 | 54 | 8 | 61 | N/A |
| 6/30/2018 | 754 | 48 | -19 | 27 | N/A |
| 3/31/2018 | 747 | 44 | N/A | 16 | N/A |
| 12/31/2017 | 713 | 31 | N/A | 25 | N/A |
| 9/30/2017 | 688 | -1 | N/A | 45 | N/A |
| 6/30/2017 | 678 | -6 | N/A | 72 | N/A |
| 3/31/2017 | 670 | -9 | N/A | 56 | N/A |
| 12/31/2016 | 696 | 10 | N/A | 50 | N/A |
| 9/30/2016 | 651 | 8 | N/A | 54 | N/A |
| 6/30/2016 | 599 | 14 | N/A | 40 | N/A |
| 3/31/2016 | 539 | 24 | N/A | 44 | N/A |
| 12/31/2015 | 485 | 31 | N/A | 38 | N/A |
| 9/30/2015 | 476 | 32 | N/A | 37 | N/A |
| 6/30/2015 | 463 | 32 | N/A | 50 | N/A |
| 3/31/2015 | 455 | 31 | N/A | 75 | N/A |
| 12/31/2014 | 441 | 31 | N/A | 65 | N/A |
| 9/30/2014 | 425 | 28 | N/A | 49 | N/A |
| 6/30/2014 | 407 | 29 | N/A | 59 | N/A |
| 3/31/2014 | 395 | 27 | N/A | 52 | N/A |
| 12/31/2013 | 381 | 24 | N/A | 55 | N/A |
| 9/30/2013 | 365 | 23 | N/A | 53 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMCL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: OMCL is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OMCL is expected to become profitable in the next 3 years.
Revenue vs Market: OMCL's revenue (4.6% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: OMCL's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMCL's Return on Equity is forecast to be low in 3 years time (7%).